Chemotherapy-induced Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy [NA]
Completed trial evaluating wearable focal vibration for chemotherapy-induced peripheral neuropathy; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy [Phase 2]
Phase 2 clinical trial assessing the efficacy of peri-neural platelet-rich plasma injections for treating chemotherapy-induced peripheral ne…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
A study at MD Anderson Cancer Center is investigating cortical mechanisms underlying chemotherapy-induced peripheral neuropathy and potentia…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy [NA]
The update describes a clinical trial investigating whether exercise can alleviate chemotherapy-induced peripheral neuropathy, in patients w…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy. [Phase 2]
A Phase 2 clinical trial called SPENDD is evaluating quantitative sensory testing and analgesic response in painful peripheral neuropathies …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy [NA]
This clinical trial entry indicates a study evaluating nerve excitability in patients with cisplatin-induced peripheral neuropathy, currentl…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy [Phase 3]
Phase 3 clinical trial evaluating mecobalamin to prevent taxane-related peripheral neuropathy. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy [NA]
An ongoing clinical trial evaluating whether a cold salt water foot bath can affect the development of chemotherapy-induced peripheral neuro…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems [NA]
Clinical trial NCT06959277 (Balance4Mobility) is recruiting to evaluate Walkasins for improving balance and gait in people with peripheral n…
-
CLINICAL_TRIALS other · 2026-04-16Clinical Trial Update: NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy [Phase 2]
Phase 2 trial from MD Anderson evaluating psilocybin to prevent chemotherapy-induced peripheral neuropathy; currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Cryocompression for CIPN [NA]
A Dana-Farber Cancer Institute-led clinical trial is evaluating cryocompression for chemotherapy-induced peripheral neuropathy, including ta…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy [NA]
A clinical trial evaluating scrambler therapy for chemotherapy-induced peripheral neuropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Prospective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral Neuropathy (CIPN)
This clinical trial update describes an exploratory study assessing a multiomic blood biomarker panel to predict chemotherapy-induced periph…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy [Phase 1]
Phase 1 trial evaluating CBG/CBD oil for chemotherapy-induced peripheral neuropathy; recruitment has not yet begun.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients [NA]
This entry reports a completed pilot study evaluating acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer patients.
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) [Phase 2]
Phase II trial evaluating GM1 ganglioside to reduce or prevent paclitaxel-induced peripheral neuropathy in metastatic breast cancer has been…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Physiologic Measure of VIPN
A ClinicalTrials.gov study at Children's National Research Institute is evaluating a physiologic measure of chemotherapy-induced peripheral …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Whole-Body Vibration on Balance, Risk of Falling and Quality of Life in Chemotherapy-Induced Peripheral Neuropathy [NA]
This study from Cairo University is evaluating whether whole-body vibration can improve balance, reduce fall risk, and enhance quality of li…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: The Lilac Device Trial [NA]
A clinical trial update indicates that the Lilac Device trial by Luminate Medical is currently recruiting for chemotherapy-induced periphera…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy [Phase 3]
This Phase 3 trial compares the capsaicin 179 mg patch to duloxetine for chemotherapy-induced peripheral neuropathy and is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy
A clinical trial is evaluating intrathecal ziconotide for chemotherapy-induced peripheral neuropathy, and the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) [Phase 2]
Phase 2 clinical trial evaluating the analgesic efficacy and safety of topical VMD-3866 gel for chemotherapy-induced peripheral neuropathy, …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: The Effect of Low Frequency Soundwave Stimulation on Chemotherapy Induced Peripheral Neuropathy [NA]
Clinical trial update on using low frequency soundwave stimulation to treat chemotherapy-induced peripheral neuropathy in gynecologic cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: The Effect of Electrostimulation and Compression Applications on Neuropathy Symptoms and Quality of Life in the Management of Chemotherapy-Induced Peripheral Neuropathy in Gastrointestinal System Cancer Patients Receiving Oxaliplatin-Based Treatment [NA]
Completed clinical trial evaluating whether electrostimulation and compression can reduce chemotherapy-induced peripheral neuropathy symptom…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN) [Phase 3]
Phase 3 trial evaluating a virtual exercise-based rehabilitation program to treat persistent chemotherapy-induced peripheral neuropathy; the…